Nasal spray shows promise for Hard-to-Treat depression

NCT ID NCT05660642

Recruiting now Symptom relief Sponsor: Beckley Psytech Limited Source: ClinicalTrials.gov ↗

First seen Dec 16, 2025 · Last updated May 22, 2026 · Updated 16 times

Summary

This study tests an experimental nasal spray called BPL-003, given with psychological support, to see if it is safe and can help people with treatment resistant depression. About 64 adults who have not gotten better with at least two prior depression treatments will receive one or two doses. The main goal is to check for side effects and measure changes in mood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hammersmith Medicines Research
RECRUITING

London, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
King's College London, Clinical Trials Facility
COMPLETED

London, United Kingdom
MAC Clinical Research
RECRUITING

Liverpool, L34 1BH, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TREATMENT RESISTANT DEPRESSION